Moderna Inc. Stock Rallies 13.1%, Outperforms Peers
Dow Jones2026/11/04 21:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. climbed 13.1% to $258.38 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.4% to 25,736.51 and the Dow Jones Industrial Average rising 3.0% to 53,356.12.
This was the stock's second consecutive day of gains.
Moderna Inc. hit a new 52-week high, surpassing its previous peak of $254.48, which the company achieved on October 21st.
The stock outperformed some of its peers, as Johnson & Johnson rose 3.8% to $276.32, Pfizer Inc. rose 2.6% to $30.79, and Gilead Sciences Inc. rose 4.19% to $174.48.
Trading volume totaled 14.7 million, compared to the 50-day average of 17.9 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 04, 2026 16:34 ET (21:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Tom Lee Says a VIX Signal Points to a Stock Market Bottom
Is AI an engine or a killer? Morgan Stanley provides answers with data: productivity soars, but nearly 90% of the benefits are taken by 12 industries
Morgan Stanley stated that the productivity dividends from AI are concentrated in 12 highly exposed industries, with growth rates reaching twice the twenty-year average. For the first time, signs of job replacement have emerged.
Crypto prices
More
